Cutaneous immune-related adverse reactions induced by immune checkpoint inhibitors / 中华皮肤科杂志
Chinese Journal of Dermatology
;
(12): 1026-1030, 2022.
Artículo
en Chino
| WPRIM
| ID: wpr-957766
ABSTRACT
As a new type of anti-cancer drugs, immune checkpoint inhibitors have been widely used for the treatment of various tumors in recent years, but they have also caused a variety of immune-related adverse reactions, among which cutaneous adverse reactions are the most common. The onset of cutaneous adverse reactions is usually early, and most are mild, but some can also be life-threatening. This review summarizes recent advances in cutaneous immune-related adverse reactions induced by immune checkpoint inhibitors.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Dermatology
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS